|
cont. from
Archana R, Namasivayan A. Antistressor effect of Withania somnifera. J
Ethnopharmacol. 1999;64:91-93.
Bird TD. Alzheimer's disease and other primary dementias. In: Fauci AS,
Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles of Internal
Medicine. 14th ed. New York, NY: McGraw-Hill; 1998:2348-2352.
Blumenthal M, ed. Herbal Medicine: Expanded Commission E. Newton, Mass:
Integrative Medicine Communications, Inc.; 2000.
Bone K. Botanical therapies for Alzheimer's disease. Presented at: Clinical
Practice and Assessment Skills. American Herbalist Guild Symposium 2000; October
20-22, 2000; Mount Madonna, Watsonville, Calif.
Bottiglieri T, Godfrey P, Flynn T, Carney MWP, Toone BK, Reynolds EH.
Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of
treatment with parental and oral -adenosylmethionine. J Neurol Neurosurg
Psychiatry. 1990;53:1096-1098.
Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr.
2000;71(suppl):621S-629S.
Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Veland PM. Folate, vitamin
B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch
Neurol. 1998;55:1449-1455.
Dhuley JN. Effect of ashwagandha on lipid peroxidation in stress-induced
animals. J Ethnopharmacol. 1998;60:173-178.
Diamond BJ, Shiflett SC, Feiwel N, et al. Ginkgo biloba extract: mechanisms
and clinical indications. Arch Phys Med Rehabil. 2000;81:669-678.
Ernst E, Pittler MH. Ginkgo biloba for dementia: a systematic review of
double-blind, placebo-controlled trials. Clin Drug Invest. 1999;17:301-308.
Forbes DA. Strategies for managing behavioural symptomatology associated with
dementia of the Alzheimer type: a systematic overview. Can J Nurs Res.
1998;30:67-86.
Gwyther LP. Social issues of the Alzheimer's patient and family. Am J Med.
1998;104(4A):17S-21S.
Hagerty E. Twelve steps for caregivers. American Journal of Alzheimer's Care
and Related Disorders and Research. November-December 1989;4(6). Accessed at
http://www.alzheimers.org/ on February 16, 2001.
Hendrie HC, Ogunniyi A, Hall KS, et al. Incidence of dementia and Alzheimer
disease in 2 communities. JAMA. 2001;285(6):739-747.
Higgins JPT, Flicker L. Lecithin for dementia and cognitive impairment
(Cochrane Review). In: The Cochrane Library, Issue 4, 2000. Oxford: Update
Software.
Jimenez-Jimenez FJ, Molina JA, de Bustos F, et al. Serum levels of
beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's
disease. Eur J Neurol. 1999;6:495-497.
Kidd PM. A review of nutrients and botanicals in the integrative management
of cognitive dysfunction. Altern Med Rev. 1999;4:144-161.
Kim EJ, Buschmann MT. The effect of expressive physical touch on patients
with dementia. International Journal of Nursing Studies. 1999;36:235-243.
Koger SM, Brotons M. Music therapy for dementia symptoms (Cochrane Review).
In: The Cochrane Library, Issue 4, 2000. Oxford: Update Software.
Kumar AM, Tims F, Cruess DG, et al. Music therapy increases serum melatonin
levels in patients with Alzheimer's disease. Altern Ther Health Med.
1999;5:49-57.
Le Bars PL, Katz MM, Berman N, et al. A placebo controlled, double-blind,
randomized trial of an extract of Ginkgo biloba for dementia. JAMA.
1997;278:1327-1332.
Le Bars PL, Kieser M, Itil KZ. A 26-week analysis of a double-blind,
placebo-controlled trial of the Ginkgo biloba extract EGb761 in dementia. Dement
Geriatr Cogn Disord. 2000;11:230-237.
Lim GP, Yang F, Chu T, et al. Ibuprofen suppresses plaque pathology and
inflammation in a mouse model for Alzheimer's disease. J Neurosci.
2000;20(15):5709-5714.
Masaki KH, Losonczy KG, Izmirlian G. Association of vitamin E and C
supplement use with cognitive function and dementia in elderly men. Neurology.
2000;54:1265-1272.
Mantle D, Pickering AT, Perry AK. Medicinal plant extracts for the treatment
of dementia: a review of their pharmacology, efficacy and tolerability. CNS
Drugs. 2000;13:201-213.
Morris MC, Beckett LA, Scherr PA, et al. Vitamin E and vitamin C supplement
use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord.
1998;12:121-126.
Morrison LD, Smith DD, Kish SJ. Brain S-adenosylmethione levels are severely
decreased in Alzheimer's disease. J Neurochem. 1996;67:1328-1331.
Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive
funciton in Alzheimer disease. Arch Neurol. 1998;55:1409-1415.
Ott BR, Owens NJ. Complementary and alternative medicines for Alzheimer's
disease. J Geriatr Psychiatry Neurol. 1998;11:163-173.
Pettegrew JW, Levine J, McClure RJ. Acetyl-L-carnitine physical-chemical,
metabolic, and therapeutic properties: relevance for its mode of action in
Alzheimer's disease and geriatric depression. Mol Psychiatry. 2000;5:616-632.
Pitchumoni SS, Doraiswamy M. Current status of antioxidant therapy for
Alzheimer's disease. J Am Geriatr Soc. 1998;46:1566-1572.
Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol,
or both as treatment for Alzheimer's disease. N Engl J Med. 1997;336:1216-1222.
Scherder EJ, Bouma A, Steen AM. Effects of short-term transcutaneous
electrical nerve stimulation on memory and affective behaviour in patients with
probable Alzheimer's disease. Behav Brain Res. 1995;67(2):211-219.
Scherder EJ, Van Someren EJ, Bouma A, vd Berg M. Effects of transcutaneous
electrical nerve stimulation (TENS) on cognition and behavior in aging. Behav
Brain Res. 2000;111(1-2):223-225.
Snowdon DA, Tully CL, Smith CD, Riley KR, Markesbery WR. Serum folate and the
severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun
Study. Am J Clin Nutr. 2000;71:993-998.
Spagnoli A, Lucca U, Menasce G, et al. Long-term acetyl-L-carnitine treatment
in Alzheimer's disease. Neurology. 1991;41:1726-1732.
Tabak N, Ehrenfeld M, Alpert R. Feelings of anger among caregivers of
patients with Alzheimer's disease. Int J Nurs Pract. 1997;3(2):84-88.
Tabet N, Birks J, Grimley Evans J. Vitamin E for Alzheimer's disease
(Cochrane Review). In: The Cochrane Library, Issue 4, 2000. Oxford: Update
Software.
Thal LJ, Carta A, Clarke WR, et al. A 1-year multicenter placebo-controlled
study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology.
1996;47:705-711.
Thompson C, Briggs M. Support for careers of people with Alzheimer's type
dementia. Cochrane Database Syst Rev. 2000;(2):CD000454.
Wettstein A. Cholinesterase inhibitors and ginkgo extracts—are they comparable
in the treatment of dementia? Phytomed. 2000;6:393-401.
next:
The Stages of Alzheimer's Disease .
section table of contents
top .
pages 1 2
3 4
5 6 .
send to friend .
alzheimer's site
map
Reviewed: 03/2006
|